The main result of this cross-sectional study was the presence of higher tau deposition in the AD group in the bilateral inferior lateral temporal lobe, dorsal prefrontal cortex, precuneus, posterior cingulate cortex, hippocampus, and occipital lobe. The gene discussed is MAPT; the disease is Alzheimer disease.